Arylamine N-acetyltransferase 2 expression in the developing heart.

Area of Science:

• Developmental Biology
• Biochemistry
• Cardiovascular Research

Background:

• Murine arylamine N-acetyltransferase 2 (NAT2) is known for xenobiotic metabolism.
• Emerging evidence suggests NAT2 has intrinsic biological functions.
• NAT2 expression is observed in the developing heart and neural tube.

Purpose of the Study:

• To characterize the spatiotemporal expression of NAT2 during murine cardiogenesis.
• To investigate the potential endogenous role of NAT2 in heart development.
• To assess NAT2's utility as a marker for cardiac development.

Main Methods:

• In vivo expression mapping using lacZ insertion deletion.
• In vitro measurement of NAT2 enzyme activity.
• Analysis of NAT2 expression in Nat2(-/-) and Nat2(+/-) mice.

Main Results:

• Cardiac NAT2 expression is temporally and spatially regulated during development.
• Neonatal cardiac NAT2 expression is prominent in the central fibrous body, atrioventricular valves, and great vessel valves.
• NAT2 is expressed in the sinus node region, right atrial appendage epicardium, and pulmonary artery, but not in ventricular myocardial cells.
• Peak NAT2 activity coincides with the adult circulation pattern and metabolic shift from glucose to fatty acids.
• No compensatory acetylating activity was observed in Nat2 knockout or heterozygous models.

Conclusions:

• Murine NAT2 exhibits a complex expression pattern during cardiogenesis, indicating an endogenous role.
• NAT2's specific expression suggests it may serve as a valuable marker for studying cardiac development.
• The findings differentiate NAT2's role from its classical xenobiotic metabolism function.